ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
-0,01%
Bitcoin
63.625,82
1,17%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Pluristem Therapeutics Inc (PSTI)

  7. Pluristem Therapeutics Inc (PSTI) News

PSTI

Pluristem Therapeutics (PSTI)

Pluristem Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PSTI
DatumZeitQuelleÜberschriftSymbolFirma
09/06/202312h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PSTIPluristem Therapeutics Inc
01/06/202322h06Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PSTIPluristem Therapeutics Inc
09/05/202322h17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PSTIPluristem Therapeutics Inc
25/04/202322h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
27/02/202313h58Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:PSTIPluristem Therapeutics Inc
27/02/202313h53Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PSTIPluristem Therapeutics Inc
16/02/202314h59Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:PSTIPluristem Therapeutics Inc
16/02/202314h17Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PSTIPluristem Therapeutics Inc
14/02/202312h27Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:PSTIPluristem Therapeutics Inc
13/02/202322h39Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PSTIPluristem Therapeutics Inc
06/02/202315h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
24/01/202322h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
28/12/202222h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
22/12/202214h55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PSTIPluristem Therapeutics Inc
19/12/202222h14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
10/11/202222h01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PSTIPluristem Therapeutics Inc
13/10/202222h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
29/09/202216h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
21/09/202223h17Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PSTIPluristem Therapeutics Inc
21/09/202222h03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PSTIPluristem Therapeutics Inc
25/07/202215h39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
25/07/202213h00GlobeNewswire Inc.Pluri CEO Issues Shareholder UpdateNASDAQ:PSTIPluristem Therapeutics Inc
25/07/202207h00GlobeNewswire Inc.Pluristem Therapeutics Inc. Changes its Name to “Pluri Inc.” Reflecting the Company’s Strategy to Leverage its Innovative 3D Cell-based Technology Platform to Additional IndustriesNASDAQ:PSTIPluristem Therapeutics Inc
17/07/202214h20TipRanksPluristem (PSTI) Receives a Buy from H.C. WainwrightNASDAQ:PSTIPluristem Therapeutics Inc
13/07/202215h29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
13/07/202212h00GlobeNewswire Inc.Pluristem Reports Topline Results from its Phase III Study of Muscle Regeneration Following Hip Fracture SurgeryNASDAQ:PSTIPluristem Therapeutics Inc
23/06/202222h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
15/05/202214h25TipRanksDawson James Thinks Pluristem’s Stock is Going to RecoverNASDAQ:PSTIPluristem Therapeutics Inc
28/03/202209h00GlobeNewswire Inc.Pluristem and Tnuva to Ring Nasdaq Closing Bell in Honor of New PartnershipNASDAQ:PSTIPluristem Therapeutics Inc
23/03/202212h30GlobeNewswire Inc.Pluristem Releases PLX-R18 Hematology Phase I Study Results: Data Show Increase in All Blood Lines and Reduction in Blood TransfusionsNASDAQ:PSTIPluristem Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PSTI

Kürzlich von Ihnen besucht

AMEX
XLE
Energy Select Sector SPDR
TG
CBK
Commerzbank
NASDAQ
QQQ
Invesco QQQ Trust Series 1
TG
DTE
Deutsche Telekom
TG
LHA
Deutsche Lufthansa
NASDAQ
MSFT
Microsoft
COIN
ETHUSD
Ethereum
AMEX
SPY
SPDR S&P 500
TG
D7G
Nel ASA
USOTC
ADDYY
Adidas (QX)
TG
BAS
BASF
NYSE
MRK
Merck
TG
DBK
Deutsche Bank
AMEX
XLF
Financial Select Sector
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten